Prevalence of the JAK2‐V617F mutation in Taiwanese patients with chronic myeloproliferative disorders

Abstract

The JAK2-V617F mutation can be frequently detected in the Taiwanese patients with MPD disorders and therefore should be incorporated into the initial evaluation of patients suspected of MPD.